Albert David Reports Significant Financial Declines in May 2025 Results
Albert David, a microcap pharmaceutical company, reported its financial results for the quarter ending March 2025, revealing significant challenges. Key metrics showed a decline in profit before tax, net sales, and operating profit, with the lowest sales figures recorded in five quarters and a notable drop in earnings per share.
Albert David, a microcap company in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 13, 2025, indicate a challenging period for the company, with notable shifts in its financial metrics.The evaluation changes reflect a score adjustment to -10 from -18 over the past three months. This revision highlights the ongoing difficulties faced by Albert David. The Profit Before Tax less Other Income (PBT) for the quarter stands at Rs -6.70 crore, marking a significant decline of 187.35% year on year. Additionally, net sales have also shown a downward trend, recorded at Rs 74.89 crore, which is a 15.91% decrease compared to the previous year and represents the lowest sales figure in the last five quarters.
The operating profit has similarly reached its lowest point at Rs -4.75 crore, with an operating profit margin of -6.34%, indicating a decline in the company's operational efficiency. Furthermore, the earnings per share (EPS) have fallen to Rs -18.09, reflecting a decrease in profitability and lower earnings for shareholders.
For more insights on Albert David's financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
